Skip to main content
. 2016 May 20;7(4):473–480. doi: 10.1016/j.jshs.2016.05.005

Table 1.

Psychomotor performance and exercise parameters determined before (Term I) and after (Term II) 4-week supplementation with PL or RR (mean ± SD).

Variable PL (n = 13)
RR (n = 13)
Term I Term II Term I Term II
Psychomotor performance
Simple reaction
Reaction time (A1; ms) 240.4 ± 9.7 253.5 ± 11.4 247.8 ± 12.8 226.5 ± 8.3*
Movement time (A2; ms) 97.3 ± 5.6 99.0 ± 6.3 109.3 ± 4.1 112.5 ± 7.8
Total response time (A3; ms) 337.6 ± 10.9 352.5 ± 15.1 357.1 ± 14.1 339.0 ± 13.3
Choice reaction
Number of correct responses (B1; n) 251.3 ± 9.8 267.9 ± 9.5* 232.5 ± 5.8 269.6 ± 9.5**
Number of incorrect responses (B2; n) 43.9 ± 6.9 44.8 ± 6.1 59.2 ± 5.6 50.8 ± 4.0
Response time (B3; s) 0.708 ± 0.015 0.661 ± 0.011** 0.712 ± 0.011 0.666 ± 0.016**
Exercise capacity
LArest (mmol/L) 1.45 ± 0.05 1.49 ± 0.09 1.44 ± 0.08 1.23 ± 0.07*,#
LAmax (mmol/L) 14.25 ± 1.25 15.47 ± 1.24 14.25 ± 1.13 13.29 ± 0.89
HRrest (beats/min) 70 ± 4 72 ± 2 69 ± 2 68 ± 4
HRmax (beats/min) 190 ± 2 190 ± 3 183 ± 3 184 ± 3
HRLT (beats/min) 151 ± 4 147 ± 3 150 ± 4 144 ± 3
Pmax (W) 303.5 ± 15.9 290.5 ± 15.9* 293.6 ± 13.5 307.5 ± 12.1
PLT (W) 165.6 ± 6.7 170.5 ± 6.5 172.0 ± 6.7 176.2 ± 6.2
VO2peak (mL/kg/min) 48.19 ± 1.97 47.33 ± 1.66 50.76 ± 1.95 49.37 ± 1.90
TTE (s) 789.1 ± 18.2 779.0 ± 22.8 800.0 ± 19.5 820.8 ± 28.0

Abbreviations: HRrest = heart rate at rest; HRmax = maximal heart rate; HRLT = heart rate at lactate threshold; LArest = blood lactate concentration at rest; LAmax = blood lactate concentration after an incremental cycloergometer test; Pmax = maximal power; PLT = power at lactate threshold; PL = placebo; RR = Rhodiola rosea; TTE = time to exhaustion; VO2peak = peak oxygen volume consumption.

p < 0.05, **p < 0.01, compared to Term I (within group), Wilcoxon test.

#

p < 0.05, compared with Term II in PL group, Mann–Whitney test.